<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://repository.iphce.org/xmlui/handle/123456789/5284">
<title>Health implementation guidelines &amp; standards</title>
<link>http://repository.iphce.org/xmlui/handle/123456789/5284</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://repository.iphce.org/xmlui/handle/123456789/5385"/>
<rdf:li rdf:resource="http://repository.iphce.org/xmlui/handle/123456789/5383"/>
<rdf:li rdf:resource="http://repository.iphce.org/xmlui/handle/123456789/5382"/>
<rdf:li rdf:resource="http://repository.iphce.org/xmlui/handle/123456789/5380"/>
</rdf:Seq>
</items>
<dc:date>2026-05-20T18:20:42Z</dc:date>
</channel>
<item rdf:about="http://repository.iphce.org/xmlui/handle/123456789/5385">
<title>Health and biomedical research partnership strategics document, 2025-2035</title>
<link>http://repository.iphce.org/xmlui/handle/123456789/5385</link>
<description>Health and biomedical research partnership strategics document, 2025-2035
Armauer Hansen Research Institute
Haramaya University and Armauer Hansen Research Institute run a joint PhD training program&#13;
for a decade. This strategic document is developed by the joint team to direct the Haramaya&#13;
University (HU) - Armauer Hansen research Institute (AHRI) partnership to a higher Health and&#13;
Biomedical Research partnership. The document was initially drafted by the joint team, shared&#13;
with several larger groups including senior officials, and planners to collect feedback, and&#13;
revised, refined and finalized based on the given comments. The strategic document aims at a&#13;
higher-level transformation from the previous partnership, creating a holistic collaboration&#13;
between the two institutions, focusing on Health and Biomedical Research.
</description>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.iphce.org/xmlui/handle/123456789/5383">
<title>Roadmap for medical device research and development and local productions(2026-2031)</title>
<link>http://repository.iphce.org/xmlui/handle/123456789/5383</link>
<description>Roadmap for medical device research and development and local productions(2026-2031)
Armauer Hansen Research Institute
Low- and middle-income countries (LMICs) account for approximately 80% of the global&#13;
population yet only 20% of worldwide healthcare expenditure. This disparity highlights critical&#13;
healthcare challenges in Healthcare services, particularly in the availability and functionality of&#13;
essential medical devices. Ethiopia, like many Sub-Saharan African nations, faces significant&#13;
shortages, with over 90% of medical devices imported, often leading to issues with counterfeit&#13;
products and equipment that remains non-functional due to inadequate maintenance and a&#13;
shortage of skilled workforce.
</description>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.iphce.org/xmlui/handle/123456789/5382">
<title>Grand Challenges Ethiopia: Health innovation project proposal evaluation guidelines</title>
<link>http://repository.iphce.org/xmlui/handle/123456789/5382</link>
<description>Grand Challenges Ethiopia: Health innovation project proposal evaluation guidelines
Armauer Hansen Research Institute
Grand Challenges Ethiopia: Health innovation project proposal evaluation guidelines, 2nd ed
</description>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.iphce.org/xmlui/handle/123456789/5380">
<title>Company profile for local pharmaceutical manufactures in Ethiopia</title>
<link>http://repository.iphce.org/xmlui/handle/123456789/5380</link>
<description>Company profile for local pharmaceutical manufactures in Ethiopia
Armauer Hansen Research Institute
To advance biomedical research, innovation, and capacity building in&#13;
Ethiopia and beyond, with a focus on addressing pressing public health&#13;
challenges through cutting-edge scientific discovery, translational research,&#13;
and the development of high-quality pharmaceutical and biological&#13;
products. AHRI is committed to improving health outcomes, promoting&#13;
self-reliance in healthcare, and contributing to the global fight against&#13;
infectious and non-communicable diseases.
</description>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
